Protective effects of Shexiang Xingnaonin on focal cerebral ischemia/reperfusion injury and mechanism / 中国中药杂志
Zhongguo Zhong Yao Za Zhi
; (24): 1195-1199, 2008.
Article
en Zh
| WPRIM
| ID: wpr-295381
Biblioteca responsable:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To study the protective effects of Shexiang Xingnaonin (SXN) on focal cerebral ischemia/reperfusion injury and its mechanism.</p><p><b>METHOD</b>Middle cerebral artery occlusion (MCAO) was used to make focal cerebral ischemia/reperfusion model by in travascular nylon filament occlusion. The protective effects of SXN at different doses were evaluated by investigating neurological function score, pathomorphology of brain, the ultrastructure of neuron, expression of tumor necrosis factor-alpha, thrombogenesis in vitro, platelet aggregation and lysing effect of blood clot in vitro.</p><p><b>RESULT</b>Compared with model group, SXN (0.08, 0.16 g x kg(-1)) could decrease the neurological score, improve pathomorphology and neuron ultrastructure of brain, inhibit the expression of TNF-alpha, decrease the length, wet weight and dry weight of thromb and inhibit platelet aggregation. And SXN (0.16, 0.32 g x L(-1)) could dissolve blood clot in vitro.</p><p><b>CONCLUSION</b>SXN has protective effects on focal cerebral ischemia/reperfusion injury. The role of inhibit the expression of TNF-alpha, inhibit thrombogenesis and platelet aggregation might contribute to its neuroprotective effects.</p>
Texto completo:
1
Banco de datos:
WPRIM
Asunto principal:
Encéfalo
/
Medicamentos Herbarios Chinos
/
Daño por Reperfusión
/
Distribución Aleatoria
/
Expresión Génica
/
Isquemia Encefálica
/
Agregación Plaquetaria
/
Factor de Necrosis Tumoral alfa
/
Ratas Sprague-Dawley
/
Modelos Animales de Enfermedad
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Límite:
Animals
/
Humans
/
Male
Idioma:
Zh
Año:
2008
Tipo del documento:
Article